Screening methodologies for the discovery of novel cytotoxic antitumor agents.
Casazza
A M
AM
Department of Experimental Therapeutics, Bristol Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey, USA.
Long
B H
BH
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D066298:In Vitro Techniques; D009696:Nucleic Acids / Q000187:drug effects; D010598:Pharmacognosy / Q000379:methods*; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors; D014404:Tubulin / Q000187:drug effects
D000970:Antineoplastic Agents; D009696:Nucleic Acids; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors; D014404:Tubulin